Evidence map›Paper›PMID 15361830›Full record

ArticleOncogene2004

Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks.

Giacomo Buscemi, Paola Perego, Nives Carenini, Makoto Nakanishi, Luciana Chessa, Junjie Chen, Kumkum Khanna, Domenico Delia

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 106 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. RYBP Sensitizes Cancer Cells to PARP Inhibitors by Regulating ATM Activity.International journal of molecular sciences · 2022
    Article
  8. Review
  9. The Role of Nitric Oxide in Cancer: Master Regulator or NOt?International journal of molecular sciences · 2020
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Giacomo BuscemiDepartment of Experimental Oncology, Istituto Nazionale Tumori, Via G Venezian 1, 20133 Milan, Italy.
Paola Perego
Nives Carenini
Makoto Nakanishi
Luciana Chessa
Junjie Chen
Kumkum Khanna
Domenico Delia
Fondazione IRCCS Istituto Nazionale dei Tumori · ITAzienda Ospedaliera Sant'Andrea · ITMayo Clinic · USMizuho (Japan) · JPQIMR Berghofer Medical Research Institute · AU

Funding

Telethon GP0205Y01
6 · The paper itself

Abstract

The diverse checkpoint responses to DNA damage may reflect differential sensitivities by molecular components of the damage-signalling network to the type and amount of lesions. Here, we determined the kinetics of activation of the checkpoint kinases ATM and Chk2 (the latter substrate of ATM) in relation to the initial yield of genomic DNA single-strand (SSBs) and double-strand breaks (DSBs). We show that doses of gamma-radiation (IR) as low as 0.25 Gy, which generate vast numbers of SSBs but only a few DSBs per cell (<8), promptly activate ATM kinase and induce the phosphorylation of the ATM substrates p53-Ser15, Nbs1-Ser343 and Chk2-Thr68. The full activation of Chk2 kinase, however, is triggered by treatments inflicting >19 DSBs per cell (e.g. 1 Gy), which cause Chk2 autophosphorylation on Thr387, Chk2-dependent accumulation of p21waf1 and checkpoint arrest in the S phase. Our results indicate that, in contrast to ATM, Chk2 activity is triggered by a greater number of DSBs, implying that, below a certain threshold level of lesions (<19 DSBs), DNA repair can occur through ATM, without enforcing Chk2-dependent checkpoints.

Indexed as

DNA DamageAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineCell NucleusCheckpoint Kinase 2DNADNA-Binding ProteinsDNA, Single-StrandedHumansLymphocytesPhosphorylationProtein Serine-Threonine KinasesSubstrate SpecificityTumor Suppressor ProteinsAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsCheckpoint Kinase 2CHEK2 protein, humanDNADNA-Binding ProteinsDNA, Single-StrandedProtein Serine-Threonine KinasesTumor Suppressor Proteins

Identifiers

PMID15361830
OpenAlexW1987721350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.